BHI Team Members

Dr. Stephen D. Wolpe is a distinguished biotechnology executive and scientific pioneer with over 30 years of experience in therapeutic and diagnostic development, particularly renowned for his groundbreaking discoveries in immunotherapy and inflammatory mediators. As a discoverer of the chemokine superfamily of inflammatory mediators, Dr. Wolpe has fundamentally shaped our understanding of immune system regulation and hematopoiesis.

Anna Zornosa is a seasoned healthcare entrepreneur and executive with deep expertise in building, scaling, and transforming life sciences companies at the intersection of digital technologies and health. As both a successful CEO and strategic advisor, she brings a unique combination of operational excellence, fundraising acumen, and extensive industry networks to help early-stage companies navigate the complex path from innovation to market success.